These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 15940766

  • 1. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR.
    J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Jun; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M, Jancova E, Rysava R, Merta M, Tesar V.
    Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.
    Hu W, Liu Z, Chen H, Tang Z, Wang Q, Shen K, Li L.
    Chin Med J (Engl); 2002 May; 115(5):705-9. PubMed ID: 12133539
    [Abstract] [Full Text] [Related]

  • 5. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
    Karim MY, Pisoni CN, Ferro L, Tungekar MF, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR.
    Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN.
    N Engl J Med; 2000 Oct 19; 343(16):1156-62. PubMed ID: 11036121
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan 19; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.
    J Rheumatol; 2015 Nov 19; 42(11):2082-91. PubMed ID: 26373566
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sequential therapies for proliferative lupus nephritis.
    Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.
    N Engl J Med; 2004 Mar 04; 350(10):971-80. PubMed ID: 14999109
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.
    Sundel R, Solomons N, Lisk L, Aspreva Lupus Management Study (ALMS) Group.
    Lupus; 2012 Nov 04; 21(13):1433-43. PubMed ID: 22922564
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
    Weng MY, Weng CT, Liu MF.
    Clin Rheumatol; 2010 Jul 04; 29(7):771-5. PubMed ID: 20195879
    [Abstract] [Full Text] [Related]

  • 15. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM, Tse KC, Tang CS, Mok MY, Li FK, Hong Kong Nephrology Study Group.
    J Am Soc Nephrol; 2005 Apr 04; 16(4):1076-84. PubMed ID: 15728784
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
    Kawazoe M, Kaneko K, Yamada Z, Masuoka S, Mizutani S, Yamada S, Shikano K, Sato H, Kaburaki M, Muraoka S, Kawai S, Nanki T.
    Clin Rheumatol; 2019 Jun 04; 38(6):1571-1578. PubMed ID: 30778862
    [Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z.
    Nephrology (Carlton); 2005 Oct 04; 10(5):504-10. PubMed ID: 16221103
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.
    Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, MAINTAIN Nephritis Trial Group.
    Ann Rheum Dis; 2010 Dec 04; 69(12):2083-9. PubMed ID: 20833738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.